Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine.

Altundag K., Aksoy S. , Sendur M. A. N. , Guler E. N. , Gullu I. H. , Ozisik Y. Y.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 31
  • City: Illinois
  • Country: United States Of America